HistoRxR

Clarient, HistroRxR to provide AQUA technology for clinical trials

Tuesday, October 25, 2011

Clarient, a GE Healthcare company, and HistoRxR have signed a definitive agreement to provide pharma services using AQUA technology to their growing lists of pharma clients.  By implementing HistoRx’s AQUA technology in Clarient’s CLIA laboratory, the two companies will apply their complementary capabilities to serve pharma companies’ growing need for biomarker analysis in clinical trials.  Use of tissue biomarkers to characterize a patient’s tumor is becoming a crucial element of personalized cancer care.

[Read More]